Business Context and Reporting Period
Company: Drugs Made In America Acquisition II Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: September 26, 2025
Event: Consummation of Initial Public Offering (IPO) and Private Placement.
Key Financial Metrics
| Metric | Value |
|---|---|
| IPO Units Sold | 50,000,000 |
| IPO Price per Unit | $10.00 |
| IPO Gross Proceeds | $500,000,000 |
| Private Placement Units | 1,200,000 |
| Private Placement Proceeds | $12,000,000 |
| Total Funds in Trust Account | $500,000,000 |
Note: Revenue, profit, cash flow, margins, and debt figures are not applicable as this is a pre-business combination Special Purpose Acquisition Company (SPAC) filing focused on capital raising.
Material Changes
- Capital Structure: The Company transitioned from a private entity to a public company listed on The Nasdaq Stock Market LLC.
- Securities Issued: Issued 50,000,000 Units (trading symbol: DMIIU), 50,000,000 Ordinary Shares (DMII), and 50,000,000 Rights (DMIIR).
- Liquidity: Established a trust account holding $500,000,000 for the benefit of public shareholders.
Outlook and Management Commentary
The filing confirms the successful closing of the IPO and a simultaneous private placement. The private placement was purchased by Drugs Made In America Acquisition II LLC (700,000 units) and Cantor Fitzgerald & Co. (500,000 units) at $10.00 per unit. The Company is designated as an emerging growth company. No specific business combination target or operational guidance is provided in this filing, as the Company is in the initial capital formation stage.
Investor Verification Checklist
- Verify the exact amount of underwriting discounts and commissions deducted from the $500,000,000 gross proceeds to determine net cash available outside the trust.
- Confirm the terms of the Rights attached to the Units, specifically the conversion ratio (1/10 share) upon a business combination.
- Review the full Balance Sheet (Exhibit 99.1) referenced in the filing for details on working capital and any initial working capital loans.
- Check for any redemption rights available to public shareholders prior to the initial business combination.